| 23rd Sep 2022 7:00 am |
RNS |
NXP002 Update |
| 23rd Sep 2022 7:00 am |
RNS |
NXP002 Update |
| 25th Aug 2022 2:39 pm |
RNS |
Result of AGM |
| 19th Aug 2022 8:57 am |
RNS |
Holding(s) in Company |
| 10th Aug 2022 7:00 am |
RNS |
NXP002 Completion of Tolerability Studies |
| 1st Aug 2022 12:13 pm |
RNS |
Posting of Annual Report and Notice of AGM |
| 28th Jul 2022 7:01 am |
RNS |
Board Changes |
| 28th Jul 2022 7:00 am |
RNS |
Annual Results for the year ended 31 March 2022 |
| 5th Jul 2022 7:00 am |
RNS |
NXP002 data to be presented at 2022 ERS Congress |
| 29th Jun 2022 7:00 am |
RNS |
NXP004 Update |
| 27th Jun 2022 7:00 am |
RNS |
NXP002 Update |
| 20th Jun 2022 7:00 am |
RNS |
Holding(s) in Company |
| 31st May 2022 7:00 am |
RNS |
Directorate Change |
| 30th May 2022 7:00 am |
RNS |
Corporate Update |
| 12th Apr 2022 7:00 am |
RNS |
Second tranche of Lanstead subscription shares |
| 11th Apr 2022 3:54 pm |
RNS |
Holding(s) in Company |
| 8th Apr 2022 11:21 am |
RNS |
Holding(s) in Company |
| 7th Apr 2022 3:44 pm |
RNS |
Holding(s) in Company |
| 5th Apr 2022 6:07 pm |
RNS |
Holding(s) in Company |
| 28th Mar 2022 7:00 am |
RNS |
NXP004 Patent |
| 2nd Mar 2022 7:00 am |
RNS |
Appointment of Dr Dan Gooding as Consultant |
| 1st Mar 2022 7:00 am |
RNS |
Change of Auditor |
| 14th Feb 2022 4:37 pm |
RNS |
Holding(s) in Company |
| 8th Feb 2022 7:00 am |
RNS |
Oxilio NXP-001 formulation development contract |
| 1st Feb 2022 7:00 am |
RNS |
Adviser Appointments |
| 31st Jan 2022 2:09 pm |
RNS |
Director/PDMR Shareholding |
| 31st Jan 2022 11:05 am |
RNS |
Result of General Meeting |
| 17th Jan 2022 9:56 am |
RNS |
Posting of Circular and Notice of General Meeting |
| 10th Jan 2022 4:23 pm |
RNS |
Director/PDMR Shareholding |
| 21st Dec 2021 7:00 am |
RNS |
Holding(s) in Company |
| 14th Dec 2021 2:05 pm |
RNS |
Second Price Monitoring Extn |
| 14th Dec 2021 2:00 pm |
RNS |
Price Monitoring Extension |
| 14th Dec 2021 7:01 am |
RNS |
Subscription to raise £1.65 million |
| 14th Dec 2021 7:00 am |
RNS |
Half year Report |
| 25th Nov 2021 7:00 am |
RNS |
Positive pre-clinical data on NXP002 |
| 17th Nov 2021 9:34 am |
RNS |
Holding(s) in Company |
| 12th Nov 2021 7:00 am |
RNS |
NXP004 patent application filing |
| 9th Nov 2021 7:00 am |
RNS |
Directorate Change |
| 4th Oct 2021 2:01 pm |
RNS |
Price Monitoring Extension |
| 16th Sep 2021 2:14 pm |
RNS |
Director/PDMR Shareholding - Replacement |
